• 011-26907444
  • raghava@iiitd.ac.in

Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES details
Primary information
ID antitb_1389,
Name21790937
N-Terminal modificationLL-37
C-Terminal ModificationLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature38
SourceL
OriginCationic
SpeciesNatural
StrainMurine macrophages
Inhibition ConcentrationMycobacteria smegmatis
In Vitro/ In vivoM. smegmatis mc2 155
Cell LineMIC = 1μg /ml
Inhibition Concentrationin vitro
Sequence2011
CytotoxicityJ774.A1 macrophage cell lines
In vivo Model14% bacteria is cleared
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1390,
Name21790937
N-Terminal modificationLL-37
C-Terminal ModificationLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature38
SourceL
OriginCationic
SpeciesNatural
StrainMurine macrophages
Inhibition ConcentrationMycobacteria smegmatis
In Vitro/ In vivoM. smegmatis mc2 155
Cell LineMIC = 1μg /ml (after 6 hours)
Inhibition Concentrationin vitro
Sequence2011
CytotoxicityJ774.A1 macrophage cell lines
In vivo Model34% bacteria is cleared
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1391,
Name21790937
N-Terminal modificationLL-37
C-Terminal ModificationLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature38
SourceL
OriginCationic
SpeciesNatural
StrainMurine macrophages
Inhibition ConcentrationMycobacteria smegmatis
In Vitro/ In vivoM. smegmatis mc2 155
Cell LineMIC = 25μg/ml
Inhibition Concentrationin vitro
Sequence2011
CytotoxicityJ774.A1 macrophage cell lines
In vivo Model41% bacteria is cleared
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1392,
Name21790937
N-Terminal modificationLL-37
C-Terminal ModificationLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature38
SourceL
OriginCationic
SpeciesNatural
StrainMurine macrophages
Inhibition ConcentrationMycobacteria smegmatis
In Vitro/ In vivoM. smegmatis mc2 155
Cell LineMIC = 25μg /ml (after 6 hours incubation)
Inhibition Concentrationin vitro
Sequence2011
CytotoxicityJ774.A1 macrophage cell lines
In vivo Model67% bacteria is cleared
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1399,
Name21790937
N-Terminal modificationLL-37
C-Terminal ModificationLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature38
SourceL
OriginCationic
SpeciesNatural
StrainMurine macrophages
Inhibition ConcentrationMycobacteria bovis
In Vitro/ In vivoMycobacteria bovis BCG
Cell LineMIC = 25μg/ml
Inhibition Concentrationin vitro
Sequence2011
CytotoxicityTHP-1 cells
In vivo ModelNA
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1400,
Name21790937
N-Terminal modificationLL-37
C-Terminal ModificationLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature38
SourceL
OriginCationic
SpeciesNatural
StrainMurine macrophages
Inhibition ConcentrationMycobacteria bovis
In Vitro/ In vivoMycobacteria bovis BCG
Cell LineMIC = 25μg /ml (after 624hours incubation)
Inhibition Concentrationin vitro
Sequence2011
CytotoxicityTHP-1 cells
In vivo Model> 60% bacteria is cleared
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1403,
Name21790937
N-Terminal modificationLL-37
C-Terminal ModificationLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature38
SourceL
OriginCationic
SpeciesNatural
StrainMurine macrophages
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis H37Rv
Cell LineMIC = 25μg/ml (24 hours incubation)
Inhibition Concentrationin vitro
Sequence2011
CytotoxicityNA
In vivo ModelNA
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1404,
Name21790937
N-Terminal modificationLL-37
C-Terminal ModificationLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature38
SourceL
OriginCationic
SpeciesNatural
StrainMurine macrophages
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis H37Rv
Cell LineMIC = 100 μg/mL (72 hours incubation)
Inhibition Concentrationin vitro
Sequence2011
CytotoxicityNA
In vivo ModelNA
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1528,
Name25613372
N-Terminal modificationLL-37
C-Terminal ModificationLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature37
SourceL
OriginCationic
SpeciesProtein derived
StrainDerived from Human cationic antimicrobial protein 18 (hCAP18)
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis H37Rv
Cell LineMIC = 2.1 μg/ml
Inhibition Concentrationin vitro
Sequence2015
CytotoxicityHuman macrophage THP1
In vivo ModelNA
Lethal DoseNo cytotoxicity
Immune ResponceC57BL/6 Mice
Mechanism of ActionNA
TargetInduce expression of IL-8 and MCP-1
Combination TherapyIn vitro binding of bacterilamembrane and induce pore formation while in vivo activate TLR and monocyte to kill bacteria
Other activitiesBacterial cell membrane
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1628,
Name26218806
N-Terminal modificationLL-37
C-Terminal ModificationLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature37
SourceL
OriginCationic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium smegmatis
In Vitro/ In vivoMycobacteria smegmatis mc2 155
Cell LineMIC = 2400 μg/ml
Inhibition Concentrationin vitro
Sequence2015
CytotoxicityJ774 macrophage cell lines
In vivo ModelNA
Lethal DoseIC50= 11226 μg/ml
Immune ResponceNA
Mechanism of ActionNA
TargetStimulation of TNF-α production
Combination Therapyinhibit bacterial Atpase activity
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1811,
Name23141114
N-Terminal modificationLL- 37
C-Terminal ModificationLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature37
SourceL
OriginCationic
SpeciesNatural
StrainHuman cells
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis strain H37Rv
Cell LineMIC = 5 μM
Inhibition ConcentrationBoth
Sequence2012
CytotoxicityNA
In vivo ModelNA
Lethal DoseNA
Immune ResponceMale BALB/c mice
Mechanism of Actiona significant reduction in bacilli loads
TargetNA
Combination TherapyDisruption of cell wall and membrane
Other activitiescell wall and membrane
PMIDNA
Year of PublicationAntibacterial (P.aeruginosa)
Tertiary Structure
(Technique)
Not Predicted),